These findings demonstrate that HT treatment has a potential protection on high-fat diet-induced obesity mice via activating the AMPK/ACC/CPT1 pathway, and to a certain extent, it has nothing to do with the storage time of three kinds of HT. The gene discussed is CPT1A; the disease is obesity due to melanocortin 4 receptor deficiency.